Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical Medical Device United States

CMS Still Focusing On Open Payments Education Rather Than Compliance

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Agency hasn’t yet cracked down on missing Open Payments submissions, although it has financial penalties at its disposal. Meanwhile, companies continue to face challenges in maintaining compliance to both federal and state payment disclosure requirements.

You may also be interested in...



Regulatory Science Tools For Phantoms, Lab Methods Added To US FDA Catalog

The regulatory tools are for use in medical device development.

US FDA, NIST Join Forces To Improve Manufacturing, Prevent Drug And Device Shortages

The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.

US FDA Announces 99 New Or Updated Consensus Standards

The updates reflect changes to standards on medical electrical equipment and a wide range of device types.

Table

View full table

Topics

Related Companies

Tags:
BioPharmaceutical Medical Device United States
UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By